Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasim Nehzat

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Multiple Sclerosis International|July 5, 2021
Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)Omid Mirmosayyeb, Mahdi Barzegar, Alireza Afshari-Safavi, et al.
Current Journal of Neurology|November 27, 2023
Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorderOmid Mirmosayyeb, Vahid Shaygannejad, Mahshad Afsharzadeh, et al.
Multiple Sclerosis and Related Disorders|July 12, 2020
Characteristics of COVID-19 disease in multiple sclerosis patientsMahdi Barzegar, Omid Mirmosayyeb, Mahsa Ghajarzadeh, et al.
Dysphagia|February 13, 2021
Prevalence and Risk Factors of Dysphagia in Patients with Multiple SclerosisMahdi Barzegar, Omid Mirmosayeb, Mina Rezaei, et al.
Journal of Clinical Medicine|February 15, 2022
Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease OnsetDena Sadeghi-Bahmani, Mahdi Barzegar, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders|May 29, 2020
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemicMahsa Ghajarzadeh, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Multiple Sclerosis and Related Disorders|May 8, 2019
Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controlsMahdi Barzegar, D Sadeghi Bahmani, Nasim Nehzat, et al.
Journal of Clinical Medicine|May 7, 2020
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple SclerosisOmid Mirmosayyeb, Serge Brand, Mahdi Barzegar, et al.
Psychology, Health & Medicine|December 10, 2020
Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosisMahdi Barzegar, Sepideh Allahdadian, Omid Mirmosayyeb, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 21, 2021
COVID-19 Among Patients With Multiple Sclerosis: A Systematic ReviewMahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Multiple Sclerosis International|July 5, 2021
Evaluation of Month of Birth in Neuromyelitis Optica Spectrum Disorders (NMSOD) and Multiple Sclerosis (MS)Omid Mirmosayyeb, Mahdi Barzegar, Alireza Afshari-Safavi, et al.
Current Journal of Neurology|November 27, 2023
Psychometric assessment of the Persian version of the patient determined disease steps scale in patients with multiple sclerosis and neuromyelitis optica spectrum disorderOmid Mirmosayyeb, Vahid Shaygannejad, Mahshad Afsharzadeh, et al.
Multiple Sclerosis and Related Disorders|July 12, 2020
Characteristics of COVID-19 disease in multiple sclerosis patientsMahdi Barzegar, Omid Mirmosayyeb, Mahsa Ghajarzadeh, et al.
Dysphagia|February 13, 2021
Prevalence and Risk Factors of Dysphagia in Patients with Multiple SclerosisMahdi Barzegar, Omid Mirmosayeb, Mina Rezaei, et al.
Journal of Clinical Medicine|February 15, 2022
Sociodemographic and Illness-Related Indicators to Predict the Status of Neuromyelitis Optica Spectrum Disorder (NMOSD) Five Years after Disease OnsetDena Sadeghi-Bahmani, Mahdi Barzegar, Omid Mirmosayyeb, et al.
Multiple Sclerosis and Related Disorders|May 29, 2020
Favorable outcome after COVID-19 infection in a multiple sclerosis patient initiated on ocrelizumab during the pandemicMahsa Ghajarzadeh, Omid Mirmosayyeb, Mahdi Barzegar, et al.
Multiple Sclerosis and Related Disorders|May 8, 2019
Comparison of sleep complaints and quality of life between patients with neuromyelitis optica spectrum disorder (NMOSD) and healthy controlsMahdi Barzegar, D Sadeghi Bahmani, Nasim Nehzat, et al.
Journal of Clinical Medicine|May 7, 2020
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple SclerosisOmid Mirmosayyeb, Serge Brand, Mahdi Barzegar, et al.
Psychology, Health & Medicine|December 10, 2020
Short report: assessment of coping strategies in patients with neuromyelitis optica spectrum disorder (NMOSD) and multiple sclerosisMahdi Barzegar, Sepideh Allahdadian, Omid Mirmosayyeb, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|May 21, 2021
COVID-19 Among Patients With Multiple Sclerosis: A Systematic ReviewMahdi Barzegar, Omid Mirmosayyeb, Mahsa Gajarzadeh, et al.
Pageof 3